Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: The Effects of Melatonin on Elevated Liver Enzymes During Statins Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether melatonin can reduce elevated liver enzymes in patients treated with statins has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)
  • Statin (statin)

Snippet

Sponsor: Medical University of Lodz | Conditions: Hepatopathy | Phase 4 | Status: COMPLETED